Skip to main content
Industry News
Ardelyx files NDA for serum phosphorus control in CKD
7/1/2020

A new drug application was submitted to the FDA by Ardelyx for its drug tenapanor to control serum phosphorus in adult patients with chronic kidney disease who are on dialysis.

Full Story: